We overview the state of the art in the field of safe exposure levels setting for nanomaterials together with the previously published results of our experimental investigations characterizing comparative toxicity of the iron oxide (magnetite) in the form of microparticles and nanoparticles of different size and comparative activity of the defensive alveolar phagocytosis response to their pulmonary deposition. An approach to the substantiation of acceptable workplace exposure limits of metallic nanoparticles is discussed and, specifically, the tentative reference level for magnetite nanoparticles is recommended.
No takes yet. Share an insight, caveat, or question.
Katsnelson et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: